Endocrine Pathology

Journal Metrics
(Based on the publications from the last 4 years)
(from 2021-01-01 to roughly 2025-01-01)
Number of papers190
H4-Index22
TQCC9
Average citations14.695
Median citations2
Impact Factor11.300 (based on Web of Science 2023)
Twitter@EndoPath (ca. 1820 followers)

(API-Link)

Categories & Ranks
Metric:
(Based on the publications from the last 4 years)
Most cited by this journal
(Based on citations to the other journals in the most recent 30 papers in this journal, at least if metadata about citations were available; last updated 2023-08-25)
Impactful Papers
(Based on publications since 2023; last updated 2024-12-15)
Altmetric Attention Score: 17
Thyroblastoma—a Primitive Multilineage Thyroid Neoplasm with Somatic DICER1 Alteration
Endocrine Pathology 2023-02-15
Altmetric Attention Score: 15
The Impact of the 2022 WHO Classification of Thyroid Neoplasms on Everyday Practice of Cytopathology
Endocrine Pathology 2023-02-17
Altmetric Attention Score: 8
High Grade Differentiated Follicular Cell-Derived Thyroid Carcinoma Versus Poorly Differentiated Thyroid Carcinoma: A Clinicopathologic Anal
Endocrine Pathology 2023-05-21
Altmetric Attention Score: 8
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAX
Endocrine Pathology 2024-09-28
Altmetric Attention Score: 8
Progression of Low-Grade Neuroendocrine Tumors (NET) to High-Grade Neoplasms Harboring the NEC-Like Co-alteration of RB1 and TP53
Endocrine Pathology 2024-11-20
Ad
0.0061349868774414